Radiopharm Theranostics Limited American Depositary Shares
Radiopharm Theranostics Limited a clinical-stage radiotherapeutics company, engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas with high unmet medical needs. The company develops several products, including RAD101, a pivalate brain metastasis diagnostic; RAD102, a pivalate therapeutic; RAD201a, a Nano-mAb HER-2 breast diagnostic; R… Read more
Market Cap & Net Worth: Radiopharm Theranostics Limited American Depositary Shares (RADX)
Radiopharm Theranostics Limited American Depositary Shares (PINK:RADX) has a market capitalization of $37.13 Million ($37.13 Million) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #22364 globally and #7920 in its home market, demonstrating a -15.14% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Radiopharm Theranostics Limited American Depositary Shares's stock price $4.71 by its total outstanding shares 7883165 (7.88 Million).
Radiopharm Theranostics Limited American Depositary Shares Market Cap History: 2025 to 2025
Radiopharm Theranostics Limited American Depositary Shares's market capitalization history from 2025 to 2025. Data shows growth from $37.13 Million to $37.13 Million (0.00% CAGR).
Index Memberships
Radiopharm Theranostics Limited American Depositary Shares is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.24 Trillion | 0.00% | #599 of 976 |
|
NASDAQ Composite
IXIC
|
$33.39 Trillion | 0.00% | #1986 of 3165 |
Weight: Radiopharm Theranostics Limited American Depositary Shares's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Radiopharm Theranostics Limited American Depositary Shares Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Radiopharm Theranostics Limited American Depositary Shares's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
10.22x
Radiopharm Theranostics Limited American Depositary Shares's market cap is 10.22 times its annual revenue
1728.56x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2025 | $37.13 Million | $3.63 Million | -$38.34 Million | 10.22x | N/A |
Competitor Companies of RADX by Market Capitalization
Companies near Radiopharm Theranostics Limited American Depositary Shares in the global market cap rankings as of March 18, 2026.
Key companies related to Radiopharm Theranostics Limited American Depositary Shares by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Radiopharm Theranostics Limited American Depositary Shares Historical Marketcap From 2025 to 2025
Between 2025 and today, Radiopharm Theranostics Limited American Depositary Shares's market cap moved from $37.13 Million to $ 37.13 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $37.13 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Radiopharm Theranostics Limited American Depositary Shares was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $37.13 Million USD |
| MoneyControl | $37.13 Million USD |
| MarketWatch | $37.13 Million USD |
| marketcap.company | $37.13 Million USD |
| Reuters | $37.13 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.